Genetic variants of the 5-HT2A serotonin receptor may explain why some respond to psychedelic therapies for the treatment of mental health disorders while others don't.from Neuroscience News https://ift.tt/nWVJI0z
In this podcast, Dr Heidi Moawad interviews a neurologist currently researching new, available treatments in headache medicine. from Front page feed http://bit.ly/2HVwnPv
Comments
Post a Comment